Latest KFF Health News Stories
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Sickened By Billing Abuses, Readers And Tweeters Stand Up For Patients’ Rights
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
In Tiny Doses, An Addiction Medication Moonlights As Treatment For Chronic Pain
Naltrexone, commonly used for opioid and alcohol use disorders, may also help patients with chronic pain — when prescribed in low doses. But few doctors or patients seem to know about it.
Doctors And Nurses With Addictions Often Denied A Crucial Recovery Option
Programs for health care professionals addicted to opioids generally bar a proven recovery method: the use of drugs like buprenorphine and methadone to relieve cravings.
Longtime Crusader Against OxyContin Begins To See The Fruits Of Her Struggle
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
‘Crackhouse’ Or ‘Safehouse’? U.S. Officials Try To Block Philly’s Supervised Injection Site
An average of three people a day died of opioid overdose in Philadelphia in 2018. But efforts to combat the crisis with a supervised injection site could be stymied by “the crackhouse statute,” a portion of federal law meant to protect neighborhoods during the crack epidemic of the 1980s.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Listen: India Gives Opioid Makers A Huge And Growing New Market
KHN’s Sarah Varney discussed opioid painkillers in India with NPR’s Rachel Martin on “Morning Edition” Thursday.
KHN’s ‘What The Health?’: Waiting For The Trump Health Plan
President Donald Trump keeps promising a new health plan, but so far it’s nowhere to be seen. Meanwhile, Democratic presidential candidate Sen. Bernie Sanders (I-Vt.) is proposing a plan to cancel billions of dollars in medical debt owed by patients. This week, Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss these issues and more. Rovner also interviews KHN’s Rachel Bluth about the latest “Bill of the Month” feature. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
Regreso a clases 2019: mochilas, loncheras y test de drogas
Según expertos, el aumento en las pruebas de drogas es una reacción a la epidemia de opioides y a las leyes de marihuana liberalizadas que se extienden por todo el país.
Back To School 2019: Backpack, Lunchbox And A Drug Test
As schools begin a new year, more districts will test students as young as 11 for illicit drug use even as other drug prevention efforts are scaled back. More than 1 in 3 school districts nationwide give students drug tests.
Americans More Likely Than Swedes To Fill Prescriptions For Opioids After Surgery
New research published in JAMA Network Open quantified for the first time international differences in doctors’ prescribing habits and patients’ use of these highly addictive painkillers.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
In India’s Slums, ‘Painkillers Are Part Of The Daily Routine’
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients’ pain, the nation’s sprawling, cash-fed health care system is ripe for misuse.
Beset By Lawsuits And Criticism In U.S., Opioid Makers Eye New Market In India
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
Judge Cites Opioid ‘Menace,’ Awards Oklahoma $572M In Landmark Case
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Doctors Can Change Opioid Prescribing Habits, But Progress Comes In Small Doses
Research out Wednesday indicates that guidelines are making strides in cutting back the number of pain pills doctors offer after specific types of surgeries.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
